Overview

Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients

Status:
Completed

Trial end date:
2013-04-01

Target enrollment:
0

Participant gender:
All

Summary

It has been shown that the stress that occurs during cardiac surgery leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to complications after surgery. This study will investigate the effects of high doses of intravenous (IV) Vitamin C on the outcome and complications after cardiac surgery.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Rutgers, The State University of New Jersey

Treatments:

Ascorbic Acid
Vitamins

Criteria

Inclusion Criteria:

- Adult patients 18 years or older undergoing elective or urgent (prior to hospital
discharge) cardiac surgery.

Exclusion Criteria:

- History of renal insufficiency, nephrolithiasis, G6PD (glucose-6-phosphate
dehydrogenase deficiency) or the chronic use of steroids.